Archives
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Clozapine N-oxide (CNO) in Chemogenetic Assays: Data-Back...
2026-02-20
This article addresses practical laboratory challenges faced by biomedical researchers and technicians when leveraging Clozapine N-oxide (CNO, SKU A3317) in cell viability, neuronal modulation, and chemogenetic workflows. Drawing on published data and real-world scenarios, it demonstrates how CNO enhances reproducibility, assay sensitivity, and experimental workflow safety in neuroscience research.
-
Palonosetron Hydrochloride (SKU B2229): Optimizing 5-HT3 ...
2026-02-19
This article addresses common pitfalls in cell-based 5-HT3 receptor and transporter inhibition assays, illustrating how Palonosetron Hydrochloride (SKU B2229) from APExBIO provides reproducible, highly selective inhibition and practical workflow advantages. Researchers will find scenario-driven guidance on protocol optimization, data interpretation, and product selection, ensuring experimental rigor for cancer research and beyond.
-
Escitalopram (SKU B1183): Reliable SSRI for Cell-Based As...
2026-02-19
This article provides scenario-driven guidance for biomedical researchers using Escitalopram (SKU B1183) in cell viability, proliferation, and cytotoxicity assays. Drawing on validated workflows and comparative data, it demonstrates how APExBIO’s high-purity, selective serotonin reuptake inhibitor supports reproducibility and sensitivity in depression and anxiolytic activity research.
-
Cisapride (R 51619): Deep Profiling for Cardiotoxicity an...
2026-02-18
Explore the multifaceted role of Cisapride, a nonselective 5-HT4 receptor agonist and hERG potassium channel inhibitor, in advanced cardiac electrophysiology and gastrointestinal motility studies. This article delivers a comprehensive scientific analysis, unique methodological insights, and strategic guidance for translational researchers.
-
Cimetidine as a Distinct H2R Modulator: Mechanistic Insig...
2026-02-18
Cimetidine, an established histamine-2 receptor antagonist with unique partial agonist activity, is redefining the landscape of translational research in gastrointestinal oncology and blood-brain barrier (BBB) modeling. This article bridges the gap between mechanistic pharmacology and practical bench-to-bedside applications, offering deep insights for researchers striving to unravel H2 receptor signaling, optimize experimental workflows, and advance reproducibility in high-impact studies. Drawing on recent model developments and comparative literature, we position APExBIO’s high-purity Cimetidine as an essential tool for the next generation of translational experiments.
-
Tropisetron Hydrochloride: Unlocking Precision in 5-HT3 R...
2026-02-17
Tropisetron Hydrochloride is a highly selective 5-HT3 receptor antagonist and α7-nicotinic receptor agonist, enabling reproducible, high-resolution studies of serotonin signaling and neurological disorder models. Its robust solubility and validated IC50 make it a gold standard for pharmacological and neuroscience workflows, with APExBIO’s stringent quality control ensuring consistent experimental performance.
-
Cisapride (R 51619): Next-Generation Strategies for Cardi...
2026-02-17
Explore how Cisapride (R 51619), a nonselective 5-HT4 receptor agonist and potent hERG potassium channel inhibitor, is redefining the translational research landscape. This thought-leadership piece fuses mechanistic insight with strategic guidance—examining deep learning-enabled phenotypic screening, iPSC-derived cardiomyocyte models, and the unique strengths of APExBIO’s high-purity offering—in order to accelerate discovery and de-risk preclinical pipelines.
-
Amitriptyline HCl in Neuropharmacology: Applied Workflows...
2026-02-16
Amitriptyline HCl stands out as a versatile serotonin/norepinephrine receptor inhibitor, empowering neuropharmacology and mood disorder research through robust receptor selectivity and solubility. Leverage its precise pharmacological profile for advanced CNS assay design, with troubleshooting strategies and workflow enhancements to maximize experimental reliability.
-
Mianserin Hydrochloride (SKU A1796): Data-Backed Solution...
2026-02-16
This article addresses real-world challenges in cell viability, proliferation, and cytotoxicity assays, demonstrating how Mianserin Hydrochloride (SKU A1796) provides reliable, reproducible, and data-driven solutions for biomedical researchers. By grounding each scenario in practical lab workflows and literature benchmarks, we offer actionable strategies for assay optimization and compound selection.
-
Cimetidine: Distinct Histamine-2 Receptor Antagonist for ...
2026-02-15
Cimetidine is a histamine-2 receptor antagonist and partial H2 receptor agonist with a unique pharmacological profile. It is widely used in cancer research due to its antitumor activity in gastrointestinal malignancies. Its solubility, stability, and purity make it a robust reagent for investigating H2 receptor signaling and high-throughput drug screening.
-
Adefovir: Selective HBV DNA Polymerase Inhibitor for Chro...
2026-02-14
Adefovir (GS-0393, PMEA) is a nucleotide analog antiviral agent with proven selectivity for hepatitis B virus (HBV) DNA polymerase. Its low resistance rate and distinct renal excretion profile make it a benchmark tool for HBV research. This article details Adefovir’s molecular mechanism, research applications, and integration parameters, providing factual clarity for both translational scientists and laboratory practitioners.
-
Thiothixene (SKU C8719): Data-Driven Solutions for Macrop...
2026-02-13
This article addresses key laboratory challenges in cell viability, proliferation, and cytotoxicity assays using Thiothixene (SKU C8719) as a validated solution. Drawing on mechanistic insights and published pharmacokinetic data, it provides scenario-based guidance tailored to biomedical researchers and lab technicians seeking reproducible results in dopaminergic and efferocytosis workflows. APExBIO’s Thiothixene is highlighted for its reliability, compatibility, and workflow efficiency.
-
Tropisetron Hydrochloride: A Benchmark 5-HT3 Receptor Ant...
2026-02-13
Tropisetron Hydrochloride stands out as a selective 5-HT3 receptor antagonist and α7-nicotinic receptor agonist, delivering precise control for serotonin receptor signaling research. Its high purity, robust solubility, and well-characterized inhibitory potency (IC50 70 nM) make it indispensable for advanced pharmacological and neurological studies. Discover practical workflows, troubleshooting insights, and comparative advantages for maximizing experimental impact.
-
Optimizing Cell Assays with Palonosetron Hydrochloride (S...
2026-02-12
This scenario-driven guide equips biomedical researchers and lab technicians with evidence-based strategies for deploying Palonosetron Hydrochloride (SKU B2229) in cell viability, proliferation, and transporter inhibition assays. Drawing on quantitative pharmacological data and validated protocols, the article addresses common laboratory challenges and demonstrates how Palonosetron Hydrochloride ensures reproducibility and specificity across research workflows.
-
Cimetidine (SKU B1557): Reliable H2 Antagonist for Advanc...
2026-02-12
This article addresses practical challenges in cell viability and barrier models, demonstrating how Cimetidine (SKU B1557) from APExBIO delivers reproducible, data-backed solutions for biomedical research. Scenario-driven Q&As explore experimental design, protocol optimization, and vendor selection, guiding scientists to achieve robust results while leveraging the unique pharmacological profile and validated purity of Cimetidine.